Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
NCT: NCT06082518 · ACTIVE_NOT_RECRUITING
Brief Summary
Over 500 million people have been infected with COVID-19, and to date, more than 6 million people have died. Many individuals who have recovered from COVID-19 continue to experience symptoms even after they have been "cured" of the disease. This condition is known as post COVID-19 condition, which can have serious health consequences. A common symptom among these individuals is chronic fatigue, characterized by persistent tiredness or lack of energy. This study aims to explore a novel treatment for symptoms of post COVID-19 condition, known as hyperbaric oxygen therapy. This approach has shown promise in helping people with post COVID-19 conditions and treating some other causes of fatigue. Hyperbaric oxygen therapy involves placing patients in a small chamber where they receive high oxygen gas levels. However, this treatment is expensive and time-consuming, and it is unclear if this treatment can be effectively assessed in a large-scale research study. This small study will help us decide if conducting a large research study is feasible. The investigators aim to assess if hyperbaric oxygen therapy can improve symptoms of post COVID-19 condition, such as fatigue.
Frequently Asked Questions
What is Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments?
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments is a clinical trial registered under NCT06082518. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06082518?
The current status of NCT06082518 (Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments) is: ACTIVE_NOT_RECRUITING.
When did Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments start?
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments started on 2024-01-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.